Exagen, Inc. (XGN)
4.98
-0.10
(-1.97%)
USD |
NASDAQ |
May 29, 16:00
4.99
+0.01
(+0.20%)
After-Hours: 20:00
Exagen Market Cap : 120.32M for May 29, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Myriad Genetics, Inc. | 374.96M |
| BioRestorative Therapies, Inc. | 12.18M |
| CareDx, Inc. | 1.179B |
| Natera, Inc. | 31.99B |
| Sera Prognostics, Inc. | 84.58M |
Market Cap Related Metrics
| PS Ratio | 1.665 |
| PEG Ratio | -1.221 |
| Price to Book Value | 8.337 |
| Price | 4.98 |
| Earnings Yield | -17.75% |
| PEGY Ratio | -1.221 |